JP2022551066A5 - - Google Patents

Info

Publication number
JP2022551066A5
JP2022551066A5 JP2022520062A JP2022520062A JP2022551066A5 JP 2022551066 A5 JP2022551066 A5 JP 2022551066A5 JP 2022520062 A JP2022520062 A JP 2022520062A JP 2022520062 A JP2022520062 A JP 2022520062A JP 2022551066 A5 JP2022551066 A5 JP 2022551066A5
Authority
JP
Japan
Application number
JP2022520062A
Other languages
Japanese (ja)
Other versions
JPWO2021062559A5 (https=
JP2022551066A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051330 external-priority patent/WO2021062559A1/en
Publication of JP2022551066A publication Critical patent/JP2022551066A/ja
Publication of JPWO2021062559A5 publication Critical patent/JPWO2021062559A5/ja
Publication of JP2022551066A5 publication Critical patent/JP2022551066A5/ja
Pending legal-status Critical Current

Links

JP2022520062A 2019-10-02 2020-10-02 カンナビノイド誘導体 Pending JP2022551066A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962909363P 2019-10-02 2019-10-02
US62/909,363 2019-10-02
US202062966418P 2020-01-27 2020-01-27
US62/966,418 2020-01-27
PCT/CA2020/051330 WO2021062559A1 (en) 2019-10-02 2020-10-02 Cannabinoid derivatives

Publications (3)

Publication Number Publication Date
JP2022551066A JP2022551066A (ja) 2022-12-07
JPWO2021062559A5 JPWO2021062559A5 (https=) 2023-10-11
JP2022551066A5 true JP2022551066A5 (https=) 2023-10-11

Family

ID=75336687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520062A Pending JP2022551066A (ja) 2019-10-02 2020-10-02 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US12325709B2 (https=)
EP (1) EP4037676A4 (https=)
JP (1) JP2022551066A (https=)
WO (1) WO2021062559A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
EP4065554A4 (en) 2019-11-26 2024-01-10 Canopy Growth Corporation CANNABIGEROL DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MODULATORS
KR20240096817A (ko) 2020-05-19 2024-06-26 사이빈 아이알엘 리미티드 중수소화된 트립타민 유도체 및 사용 방법
WO2022105810A1 (zh) * 2020-11-17 2022-05-27 中国科学院上海药物研究所 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用
CA3237951A1 (en) * 2021-11-10 2023-05-19 Mahmoud Mohamed Abdrabo MOUSTAFA New cannabinoid-gabapentinoid conjugates and uses thereof
WO2024231957A1 (en) * 2023-05-11 2024-11-14 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) 2'-{heterocyclyl (aryl/alkyl) methyl}-cannabidiol compounds and process for preparation thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8749598A (en) * 1997-08-26 1999-03-16 Ihara Chemical Industry Co. Ltd. Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural an d horticultural use
WO2003091189A1 (en) 2002-04-25 2003-11-06 Virginia Commonwealth University Cannabinoids
MX2007001943A (es) 2004-08-17 2007-05-09 Galderma Res & Dev Nuevos compuestos biaromaticos activadores de los receptores del tipo receptor activado del proliferador de peroxisoma (ppar) y su uso en composiciones cosmeticas o farmaceuticas.
EP2054383A2 (en) 2006-08-09 2009-05-06 SmithKline Beecham Corporation Novel compounds as antagonists or inverse agonists at opioid receptors
WO2008096769A1 (ja) 2007-02-08 2008-08-14 Daiichi Sankyo Company, Limited 置換されたセルコスポラミド誘導体を含有する医薬
RU2529484C2 (ru) 2008-05-05 2014-09-27 Санофи-Авентис Ациламино-замещенные производные конденсированных циклопентанкарбоновых кислот и их применение в качестве фармацевтических средств
JP5766617B2 (ja) 2009-02-20 2015-08-19 ユニバーシティ・オブ・カンザス 修飾された糖部分を有するノボビオシン類似体
US9254272B2 (en) 2011-11-30 2016-02-09 Sutter West Bay Hospitals Resorcinol derivatives
US9517989B2 (en) * 2012-10-17 2016-12-13 Northeastern University 2-cycloalkyl resorcinol cannabinergic ligands
EP2762134A1 (en) * 2013-02-04 2014-08-06 Bioversys AG Composition for treatment of pathogens that are resistant to tetracyclines
EA201690247A1 (ru) * 2013-07-18 2016-06-30 Новартис Аг Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения
EP2842933B1 (de) 2013-09-03 2015-07-29 Symrise AG Mischungen cannabinoider Verbindungen, deren Herstellung und Verwendung
US20180353461A1 (en) 2014-12-04 2018-12-13 Servicio Andaluz De Salud Use of cannabinoids as ceramide-generating anticancer agents in tumors of the hematopoietic and lymphoid tissues
US9717683B1 (en) 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
BR112019003024A8 (pt) * 2016-08-18 2019-09-10 Canopy Growth Corp plantas e métodos para aumentar e diminuir a síntese de canabinoides
US10640482B2 (en) * 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
WO2019234728A1 (en) 2018-06-04 2019-12-12 Al&Am Pharmachem Ltd. Cannabinolic acid derivatives and uses thereof
WO2020051099A1 (en) 2018-09-03 2020-03-12 Genentech, Inc. Carboxamide and sulfonamide derivatives useful as tead modulators
EP3886910A4 (en) 2018-11-30 2022-07-27 Canopy Growth Corporation A CANNABINOID OR A CANNABIS-CONTAINING COMPOUND, PROCESS FOR THEIR PRODUCTION AND THEIR USE
CA3138732A1 (en) 2018-11-30 2020-06-04 Canopy Growth Corporation Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use
WO2020198874A1 (en) * 2019-04-04 2020-10-08 Scf Pharma Inc. Cannabidiolic acid monoglycerides, derivatives, and uses thereof
EP3994129A4 (en) 2019-07-04 2023-01-04 Canopy Growth Corporation CANNABINOID DERIVATIVES
JP2022539400A (ja) 2019-07-04 2022-09-08 キャノピー グロウス コーポレイション カンナビノイド誘導体
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
US20220259221A1 (en) 2019-07-12 2022-08-18 Canopy Growth Corporation Cannabinoid derivatives
WO2021007659A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP4038058A4 (en) 2019-10-02 2023-10-25 Canopy Growth Corporation Cannabinoid derivatives
US20230122510A1 (en) 2019-11-26 2023-04-20 Canopy Growth Corporation Cannabinoid derivatives
EP4065554A4 (en) 2019-11-26 2024-01-10 Canopy Growth Corporation CANNABIGEROL DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MODULATORS
JP2023503330A (ja) 2019-11-26 2023-01-27 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021113958A1 (en) 2019-12-09 2021-06-17 Canopy Growth Corporation Cannabinoid derivatives
JP2023505517A (ja) 2019-12-09 2023-02-09 キャノピー グロウス コーポレイション カンナビノイド誘導体

Similar Documents

Publication Publication Date Title
JP2022551067A5 (https=)
JP2022551066A5 (https=)
CN306547609S (https=)
CN306533834S (https=)
CN305537022S (https=)
CN305536201S (https=)
CN305536168S (https=)
CN305535975S (https=)
CN305533343S (https=)
CN305532576S (https=)
CN305532383S (https=)
CN305532151S (https=)
CN305531858S (https=)
CN305531660S (https=)
CN305531150S (https=)
CN305530320S (https=)
CN305531838S (https=)
CN305527936S (https=)
CN306607940S (https=)
CN306607002S (https=)
CN306606757S (https=)
CN306604392S (https=)
CN305590390S (https=)
CN306603971S (https=)
CN306603861S (https=)